Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B7072 2-Pyridylethylamine dihydrochlorideTarget: Histamine H1 ReceptorsSummary: Histamine H1 receptor agonist
- B7083 J 104129 fumarateSummary: M3 muscarinic receptor antagonist
- B7095 L-BMAA hydrochlorideSummary: Neurotoxic glutamate agonist
- B7099 6-Hydroxydopamine hydrobromideSummary: neurotoxin that destroys dopaminergic and noradrenergic (catecholaminergic) neurons
- B7167 Sazetidine A dihydrochlorideSummary: α4β2 nicotinic acetylcholine receptor ligand
- B7196 Carbamoylcholine chloride1 CitationSummary: Cholinergic receptor agonist
- B7200 (+)-Tubocurarine chlorideSummary: nicotinic acetylcholine receptor antagonist
- B7263 AcephateSummary: Anticholinesterase insecticide
- B7264 (+)-Muscarine iodideSummary: Muscarinic acetylcholine receptor agonist
- B7277 (-)-CotinineSummary: α3/α6β2 nAChR activator